Theseu Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Theseu Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Theseu Board Today - Breaking & Trending Today

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Published: December 22, 2023

CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery,...

Source: marketscreener.com

Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash - Theseus Pharmaceuticals (NASDAQ:THRX)

Published: December 22, 2023

Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi

Source: benzinga.com

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Published: November 27, 2023

CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- On November 22, 2023, the board of directors of Theseus Pharmaceuticals, Inc. received an unsolicited joint letter from funds and persons...

Source: marketscreener.com